Steven Cohen's AGIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 6,507 shares of Agios Pharmaceuticals, Inc. (AGIO) worth $261,190, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in AGIO, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2018, adding 314,590 shares. Largest reduction occurred in Q4 2020, reducing 298,252 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Agios Pharmaceuticals (AGIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Agios Pharmaceuticals (AGIO) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +46,101 | Add 0.00% | 46,100 | $45.81 |
| Q3 2014 | -46,100 | Sold Out | 46,100 | $0.00 |
| Q4 2016 | +100,000 | New Buy | 100,000 | $41.73 |
| Q1 2017 | -37,500 | Reduce 37.50% | 62,500 | $58.40 |
| Q2 2017 | +140,500 | Add 224.80% | 203,000 | $51.45 |
| Q3 2017 | -73,360 | Reduce 36.14% | 129,640 | $66.75 |
| Q4 2017 | -38,140 | Reduce 29.42% | 91,500 | $57.17 |
| Q1 2018 | +314,590 | Add 343.81% | 406,090 | $81.78 |
| Q2 2018 | -250,890 | Reduce 61.78% | 155,200 | $84.23 |
| Q3 2018 | +20,500 | Add 13.21% | 175,700 | $77.12 |
| Q4 2018 | -20,700 | Reduce 11.78% | 155,000 | $46.11 |
| Q1 2019 | -42,542 | Reduce 27.45% | 112,458 | $67.44 |
| Q2 2019 | -105,705 | Reduce 94.00% | 6,753 | $49.90 |
| Q3 2019 | -6,753 | Sold Out | 6,753 | $0.00 |
| Q1 2020 | +130,614 | New Buy | 130,614 | $35.48 |
| Q2 2020 | +202,645 | Add 155.15% | 333,259 | $53.48 |
| Q3 2020 | +144,593 | Add 43.39% | 477,852 | $35.00 |
| Q4 2020 | -298,252 | Reduce 62.42% | 179,600 | $43.33 |
| Q1 2021 | -78,500 | Reduce 43.71% | 101,100 | $51.64 |
| Q2 2021 | -101,100 | Sold Out | 101,100 | $0.00 |
| Q3 2025 | +6,507 | New Buy | 6,507 | $40.14 |
Steven Cohen's Agios Pharmaceuticals Investment FAQs
Steven Cohen first purchased Agios Pharmaceuticals, Inc. (AGIO) in Q2 2014, acquiring 46,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Agios Pharmaceuticals, Inc. (AGIO) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to Agios Pharmaceuticals, Inc. (AGIO) was in Q1 2018, adding 406,090 shares worth $33.21 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 6,507 shares of Agios Pharmaceuticals, Inc. (AGIO), valued at approximately $261,190. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Agios Pharmaceuticals, Inc. (AGIO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in Agios Pharmaceuticals, Inc. (AGIO) was 477,852 shares, as reported at the end of Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.